|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gustin DM and Brenner DE: Chemoprevention
of colon cancer: current status and future prospects. Cancer
Metastasis Rev. 21:323–348. 2002. View Article : Google Scholar
|
|
3
|
Longley DB, Allen WL and Johnston PG: Drug
resistance, predictive markers and pharmacogenomics in colorectal
cancer. Biochim Biophys Acta. 1766:184–196. 2006.PubMed/NCBI
|
|
4
|
Sun Y, Zhao H, Guo Y, Lin F, Tang L and
Yao Y: Clinical study of combining chemotherapy of oxaliplatin or
5-fluorouracil/leucovorin with hydroxycamptothecine for advanced
colorectal cancer. Clin Oncol Cancer Res. 6:117–123. 2009.
View Article : Google Scholar
|
|
5
|
Boose G and Stopper H: Genotoxicity of
several clinically used topoisomerase II inhibitors. Toxicol Lett.
116:7–16. 2000. View Article : Google Scholar
|
|
6
|
Newman DJ, Cragg GM and Snader KM: The
influence of natural products upon drug discovery. Nat Prod Rep.
17:215–234. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gordaliza M: Natural products as leads to
anticancer drugs. Clin Transl Oncol. 9:767–776. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cho EJ, Shin JS, Noh YS, Cho YW, Hong SJ,
Park JH, Lee JY, Lee JY and Lee KT: Anti-inflammatory effects of
methanol extract of Patrinia scabiosaefolia in mice with ulcerative
colitis. J Ethnopharmacol. 136:428–435. 2011. View Article : Google Scholar
|
|
9
|
Gao L, Zhang L, Li N, Liu JY, Cai PL and
Yang SL: New triterpenoid saponins from Patrinia scabiosaefolia.
Carbohydr Res. 346:2881–2885. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ju HK, Baek SH, An RB, Bae K, Son KH, Kim
HP, Kang SS, Lee SH, Son JK and Chang HW: Inhibitory effects of
nardostachin on nitric oxide, prostaglandin E2, and tumor necrosis
factor-alpha production in lipopolysaccharide activated
macrophages. Biol Pharm Bull. 26:1375–1378. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chiu LC, Ho TS, Wong EY and Ooi VE: Ethyl
acetate extract of Patrinia scabiosaefolia downregulates
anti-apoptotic Bcl-2/Bcl-XL expression, and induces apoptosis in
human breast carcinoma MCF-7 cells independent of caspase-9
activation. J Ethnopharmacol. 105:263–268. 2006. View Article : Google Scholar
|
|
12
|
Peng J, Chen YQ, Lin JM, Zhuang QC, Xu W,
Hong ZF and Sferra TJ: Patrinia scabiosaefolia extract suppresses
proliferation and promotes apoptosis by inhibiting the STAT3
pathway in human multiple myeloma cells. Mol Med Rep. 4:313–318.
2011.PubMed/NCBI
|
|
13
|
Liu LY, Shen AL, Chen YQ, Wei LH, Lin JM,
Sferra TJ, Hong ZF and Peng J: Patrinia scabiosaefolia induces
mitochondrial-dependent apoptosis in a mouse model of colorectal
cancer. Oncol Rep. 30:897–903. 2013.PubMed/NCBI
|
|
14
|
Chen LW, Liu LY, Ye L, Shen AL, Chen YQ,
Sferra TJ and Peng J: Patrinia scabiosaefolia inhibits colorectal
cancer growth through suppression of tumor angiogenesis. Oncol Rep.
30:1439–1443. 2013.PubMed/NCBI
|
|
15
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhong W, Peng J, He H, Wu D, Han Z, Bi X
and Dai Q: Ki-67 and PCNA expression in prostate cancer and benign
prostatic hyperplasia. Clin Invest Med. 31:E8–E15. 2008.PubMed/NCBI
|
|
17
|
Nurse P: Ordering S phase and M phase in
the cell cycle. Cell. 79:547–550. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen Y, Robles AI, Martinez LA, Liu F,
Gimenez-Conti IB and Conti CJ: Expression of G1 cyclins,
cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in
androgen-induced prostate proliferation in castrated rats. Cell
Growth Differ. 7:1571–1578. 1996.PubMed/NCBI
|
|
19
|
Grana X and Redy EP: Cell cycle control in
mammalian cells: role of cyclins, cyclin dependent kinases (CDKs),
growth suppressor genes and cyclin-dependent kinase inhibitors
(CKIs). Oncogene. 11:211–219. 1995.PubMed/NCBI
|
|
20
|
Morgan DO: Principles of CDK regulation.
Nature. 374:131–134. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Harakeh S, Abu-El-Ardat K, Diab-Assaf M,
Niedzwiecki A, El-Sabban M and Rath M: Epigallocatechin-3-gallate
induces apoptosis and cell cycle arrest in HTLV-1-positive and
-negative leukemia cells. Med Oncol. 25:30–39. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kessel D and Luo Y: Cells in
cryptophycin-induced cell-cycle arrest are susceptible to
apoptosis. Cancer Lett. 151:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Purohit A, Hejaz HAM, Walden L,
MacCarthy-Morrogh L, Packham G, Potter BVL and Reed MJ: The effect
of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer
cells and induced mammary tumours. Int J Cancer. 85:584–589. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zafonte BT, Hulit J, Amanatullah DF,
Albanese C, Wang C, Rosen E, Reutens A, Sparano JA, Lisanti MP and
Pestell RG: Cell-cycle dysregulation in breast cancer: breast
cancer therapies targeting the cell cycle. Front Biosci.
5:D938–D961. 2000. View
Article : Google Scholar : PubMed/NCBI
|
